Business
Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver
Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver.
About this update from Branded Legacy Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver\r\n \r\n \r\n\r\n\r\nBranded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver\r\nEmpowering BioLegacy to Lead Innovation in Combating the Opioid Epidemic Through Advanced Manufacturing and Research\r\n\r\n\r\n\r\n\r\n\r\nVANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a pioneering biotechnology company dedicated to revolutionizing addiction treatment and harm reduction solutions, today announced that its subsidiary, BioLegacy Evaluative Group, has acquired a 22,000-square-foot commercial property in Vancouver, Canada. This strategic acquisition establishes a cutting-edge laboratory and manufacturing facility, fully compliant with Good Manufacturing Practices (GMP), positioning BioLegacy at the forefront of developing life-saving technologies to address the escalating opioid crisis. Building on Branded Legacy's recent transformative acquisition of BioLegacy Evaluative Group (formerly Menlo Health), which unlocked explosive growth potential in health innovation, as well as strategic partnerships with McMaster University for revolutionary clinical research in addiction treatment and with Stanford University's Dr. Eran Bendavid to advance evidence-based addiction solutions, this new facility represents a critical milestone in the company's overarching vision. By integrating world-class academic collaborations with in-house production capabilities, Branded Legacy is accelerating the creation of safe, effective devices and products that counteract hazardous substances and minimize associated harms, ultimately aiming to save lives and transform communities ravaged by addiction. The acquired premises feature International Organization for Standardization (ISO) Class 7 and 8 clean rooms, essential for pharmaceutical and biotechnology product development. These controlled environments maintain stringent particle limits—ensuring no more than 352,000 particles per cubic meter =0.5 µm, 83,200 =1 µm, and 2,930 =5 µm in ISO 7 spaces—to guarantee the highest quality standards for sensitive manufacturing processes. The in-house laboratory is equipped to handle a wide range of substances, ...